Orig3n
CMS Letter to Orig3n
Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.
Lab Issues Lead to Halt in Testing
WBUR reports Massachusetts has suspended COVID-19 testing at Orig3n following the discovery of "significant certification deficiencies."
FDA Grants EUAs to Coronavirus Tests From Orig3n, SDI, UNC
The FDA has also granted emergency use authorization for PCR-based tests for SARS-CoV-2 developed by Orig3n, Specialty Diagnostic Laboratories (SDI), and the University of North Carolina (UNC) Medical Center.
Former Employees Raise Testing Issues
Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.
Gene-Based Diets Don't Help Weight Loss
A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.
May 16, 2016
Interleukin Posts Increased Q1 Revenues
Mar 17, 2016
Interleukin Genetics Q4 Revenues Up 14 Percent
Aug 14, 2015
Interleukin Genetics' Q2 Revenues Decline 29 Percent
May 15, 2015
Interleukin Genetics Q1 Revenues Drop 17 Percent
Dec 24, 2014
Interleukin Genetics Secures $10M in Financing
Mar 21, 2014